fda glp-1 warning letters november 2025 issued 30 to telehealth companies for false and misleading claims about compounded products. This marks the second round of enforcement action since the agency's September crackdown on misleading FDA Says to Drop Suicide
Description
It is mandatory, by law, to report the redemption of prescriptions and births to the national registry, which provides the study of both a long and a complete follow-up period of every pregnancy
GLP-1 trends in type 2 diabetes Analysis from two EHR (electronic health record) sources in HealthVerity Marketplace shows the rapid adoption of GLP-1 therapy among people with type 2 diabetes
In randomized trials, GLP-1s produce placebo-adjusted weight reduction of 5% to 18% among individuals with obesity or overweight and weight-related complications
3.8 years) as well as the duration of therapy (2.5 years vs
